The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,233,010 in first-year total cost, median $616,505.
Most frequent study sections
- Interventions to Prevent and Treat Addictions Study Section[IPTA]1
- Special Emphasis Panel[ZRG1 RPHB-V (02)]1
Most frequent institutions
- JOHNS HOPKINS UNIVERSITY1
- MASSACHUSETTS GENERAL HOSPITAL1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | Opioid and cannabinoid combinations in laboratory and clinical pain1R01DA042751-01 | CAMPBELL, CLAUDIA MICHELLEDUNN, KELLY E | JOHNS HOPKINS UNIVERSITY, MD | $749,483 | ZRG1 |
| 2017 | Combination Therapy with Opioid and Duloxetine for Chronic Pain Management1R01DA039925-01A1 | MAO, JIANREN | MASSACHUSETTS GENERAL HOSPITAL, MA | $483,527 | IPTA |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.